NEUP

Neuphoria Therapeutics
NEUP

Overview Fund Trends Analyst Outlook Journalist POV

8 hedge funds and large institutions have $1.1M invested in Neuphoria Therapeutics in 2024 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less ownership

Funds ownership: →

less funds holding

Funds holding: →

less capital invested

Capital invested by funds: $ → $

67% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 6

Holders
8
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$161K
2
+$14.9K
3
+$2.65K
4
Northwestern Mutual Wealth Management
Northwestern Mutual Wealth Management
Wisconsin
+$133
5
Morgan Stanley
Morgan Stanley
New York
+$47

Top Sellers

1
-$26.8K
2
-$22K
3
-$20K
4
LAM
Lewis Asset Management
California
-$17.6K
5
Two Sigma Investments
Two Sigma Investments
New York
-$12.6K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$700K
2
$241K
3
$139K
4
$14.9K
5
$3.61K
6
$393
7
$133
8
$88
9
–
10
–
11
–
12
–
13
–
14
–
15
–